Corixa Antigens definition

Corixa Antigens means (i) those Antigens identified on Exhibit A attached hereto and/or (ii) those Antigens solely discovered by Corixa during the Research Program Term as may be extended in connection with and as a result of the Research Program and/or (iii) those Antigens discovered by Corixa as a result of research directed to PC during the Research Program Term as may be extended but not in connection with and not as a result of the Research Program and, subject to SB's exercize of the option set forth in Paragraph 4(d) below, during a period of two (2) years after the Research Program Term as may be extended and/or (iv) subject to SB's compliance with the terms and conditions of Paragraph 4(c) below, those Antigens in the PC Field licensed-in or otherwise acquired by Corixa during the Research Program Term as may be extended and, subject to Paragraph 4(d) below, during a period of two (2) years thereafter. As used herein, Corixa Antigens shall not include Research Program Antigens nor SB Antigens.
Sample 1Sample 2
Corixa Antigens means (i) those Antigens identified on Exhibit A attached hereto and/or (ii) those Antigens solely discovered by Corixa during the Research Program Term as may be extended in connection with and as a result of the Research Program and/or (iii) those Antigens discovered by Corixa as a result of research directed to BC during the Research Program Term as may be extended but not in connection with and not as a result of the Research Program and, subject to SB's exercize of the option set forth in Paragraph 4(d) below, during a period of [***] after the Research Program Term as may be extended and/or (iv) subject to SB's compliance with the terms and conditions of Paragraph 4(c) below, those Antigens in the BC Field licensed-in or otherwise acquired by Corixa during the Research Program Term as may be extended and, subject to Paragraph 4(d) below, during a period of [***] thereafter. As used herein, Corixa Antigens shall not include Research Program Antigens nor SB Antigens.
Sample 1
Corixa Antigens means Existing Corixa Antigens and New Corixa Antigens. As used herein, Corixa Antigens shall not include R&D Program Antigens or SB Antigens.
Sample 1

Examples of Corixa Antigens in a sentence

  • For purpose of clarity, the foregoing license shall include rights of SB to Corixa Antigens and/or Research Program Antigens in and outside the BC Field but in the Licensed Field; any commercial use of such Corixa Antigens and/or Research Program Antigens shall be subject to the royalties set forth in Section 6 in the same manner as royalties are paid on Products thereunder.

  • For purpose of clarity, the foregoing license shall include rights of SB to Corixa Antigens and/or Research Program Antigens in and outside the PC Field but in the Licensed Field; any commercial use of such Corixa Antigens and/or Research Program Antigens shall be subject to the royalties set forth in Section 6 in the same manner as royalties are paid on Products thereunder.

  • Subject to all of the terms of this Agreement, during the R&D Program Term as may be extended and any Intended Clinical Delay, Corixa shall granx XX x xight of first refusal with respect to all Diagnostics (other than TDM Products) comprised of at least one (1) Corixa Antigen(s) and/or R&D Program Antigen(s), excluding those Diagnostics that Corixa has [***].

  • With respect to all licenses granted by Corixa hereunder to Third Parties as allowed under the terms and conditions of Sections 5(d) and 5(g)(iii) for the use of Corixa Antigen(s) and/or R&D Program Antigen(s) in Diagnostic products, Corixa shall pay to SB [***] provided, however, that Corixa shall have no such payment obligation in connection with [***].


More Definitions of Corixa Antigens

Corixa Antigens means the antigens listed in Exhibit A hereto.
Sample 1

Related to Corixa Antigens

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Licensed Compound means [***].

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Antigen means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • GSK will have the meaning set forth in the Preamble.

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Merck has the meaning set forth in the preamble.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Biological Materials means certain tangible biological materials that are necessary for the effective exercise of the Patent Rights, which materials are described on Exhibit A, as well as tangible materials that are routinely produced through use of the original materials, including, for example, any progeny derived from a cell line, monoclonal antibodies produced by hybridoma cells, DNA or RNA replicated from isolated DNA or RNA, recombinant proteins produced through use of isolated DNA or RNA, and substances routinely purified from a source material included in the original materials (such as recombinant proteins isolated from a cell extract or supernatant by non-proprietary affinity purification methods). These Biological Materials shall be listed on Exhibit A, which will be periodically amended to include any additional Biological Materials that Medical School may furnish to Company.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Research Program has the meaning set forth in Section 2.1.

  • Manufacturing Technology means any and all patents, patent applications, Know-How, and all intellectual property rights associated therewith, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno- associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Collaborating physician means the physician who,

  • ISIS means the department’s individualized services information system.

  • Novartis shall have the meaning set forth in the Preamble.

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.